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Abstract
Background: Determining the correct number of positive immune cells in immunohistological sections of colorectal cancer
and other tumor entities is emerging as an important clinical predictor and therapy selector for an individual patient. This
task is usually obstructed by cell conglomerates of various sizes. We here show that at least in colorectal cancer the inclusion
of immune cell conglomerates is indispensable for estimating reliable patient cell counts. Integrating virtual microscopy and
image processing principally allows the high-throughput evaluation of complete tissue slides.
Methodology/Principal findings: For such large-scale systems we demonstrate a robust quantitative image processing
algorithm for the reproducible quantification of cell conglomerates on CD3 positive T cells in colorectal cancer. While
isolated cells (28 to 80 mm
2) are counted directly, the number of cells contained in a conglomerate is estimated by dividing
the area of the conglomerate in thin tissues sections (#6 mm) by the median area covered by an isolated T cell which we
determined as 58 mm
2. We applied our algorithm to large numbers of CD3 positive T cell conglomerates and compared the
results to cell counts obtained manually by two independent observers. While especially for high cell counts, the manual
counting showed a deviation of up to 400 cells/mm
2 (41% variation), algorithm-determined T cell numbers generally lay in
between the manually observed cell numbers but with perfect reproducibility.
Conclusion: In summary, we recommend our approach as an objective and robust strategy for quantifying immune cell
densities in immunohistological sections which can be directly implemented into automated full slide image processing
systems.
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Introduction
In situ immunohistochemical staining of tumor-infiltrating
immune cells against the immune cell surface molecules CD3,
CD8, CD45RO and Granzyme B in large cohorts of human
colorectal cancers [1–3] supports the hypothesis that the adaptive
immune response influences the behavior of human tumors. It is
important to note that the observed immune cell densities were
better predictors of prognosis than the classical TNM classification
[4–6], initiating a debate on the feasibility of individualized
prognosis prediction based on immune cell densities. Early data
also indicates a relation of immune cell density to chemotherapy
efficacy [7], making detailed quantification of immunologic tumor
infiltrating cells even more attractive for clinical decisions. Tumor-
infiltrating immune cells therefore represent a valuable prognostic
tool in the treatment of colorectal cancer, a high density of
immune cells being associated with good outcome independently
of other established prognostic markers. In other tumor entities the
prognostic value of these immune cells could also be demonstrated
[8–12]. Immunohistochemical quantitative analysis of immune cell
surface markers can therefore be regarded as an important
prognostic and predictive tool, requiring a high standard of
precision and reproducibility for individualized patient care.
Virtual microscopy (VM) represents an important technological
advancement in histology as it allows for the first time the
automated high throughput microscopy of complete microscopic
slides. By its ability to automatically microscope a full glass slides,
VM can deliver unprecedented spatial expression data, visualizing
spatial heterogeneity of histological parameters on the level of the
individual patient. The capabilities of the new VM technology
facilitate the solution of some long standing problems in diagnostic
histology.
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7847Here we study the contribution of VM to the quantitative
analysis of immune cell densities which is regularly obstructed by
the presence of immune cell conglomerates. Traditionally, manual
cell counts by observers are regarded as the gold standard in
histopathological quantification. But for independent observers it
is frequently rather difficult to reproduce quantities of cell densities
roughly estimated by others [13,14]. This is especially the case
with the difficult estimation of the number of cells contained in
complex cell conglomerates (see figure 1), leading to incomplete
evaluations of slides [15]. Instead, combining full slide scanning by
VM with automatic whole slide image processing provides the
basis for developing an algorithmic solution for estimating these
cell conglomerates. On the one hand such an algorithm allows the
automatic evaluation of large batches of immunohistological slides
in an automatic high-throughput manner. On the other hand, it
also ensures the comprehensive, objective, reproducible and
quantitative evaluation of the respective slides. In this article we
present such an algorithmic approach which yields robust and
reliable estimations of cell densities in even in large cell
conglomerates.
Materials and Methods
Tissue Selection
The presented analysis comprises 20 samples from colorectal
cancer primary tumors, 12 liver metastases, 10 normal colon
mucosa and 10 liver samples. Approval from the medical ethics
committee at the University of Heidelberg was obtained and
written informed consent was obtained from all patients.
Immunohistochemical Staining
Tissue specimens were immunohistochemically analyzed for
their overall infiltration with T cells (CD3-positive cells). Tissue
sections (2 mm) were prepared from formalin-fixed, paraffin-
embedded material. After deparaffinization and rehydration, the
slides were boiled in 10 mM citrate buffer (pH 6) for 15 minutes to
retrieve the antigens. The endogenous peroxidase activity was
blocked by incubation with 0.6% H2O2 in methanol for 20
minutes. The sections were blocked with 10% normal horse serum
(VectastainH Elite ABC kit, Vector, USA). Mouse monoclonal
antibodies recognizing human CD3 (1:50 dilution, clone PS1,
Acris, Germany). This antibody was applied as primary antibody
at room temperature for 2 hours. The slides were incubated with a
biotinylated secondary antibody (1:50 dilution, horse-anti-mouse
IgG, VectastainH Elite ABC kit, Vector, USA) for 30 minutes at
room temperature and AB reagent was applied according to the
manufacturer’s instructions (VectastainH Elite ABC kit, Vector,
USA). The antigen detection was performed by a color reaction
with 3,3-di-amino-benzidine (DAB+ chromogen, DakoCytoma-
tion, USA). The sections were counterstained with hematoxylin
(AppliChem, Germany) and mounted with Aquatex (Merck,
Germany).
Evaluation of Immune Cell Densities
From twenty sections across primary colorectal cancer, ten
sections of normal colon mucosa, ten sections of normal liver and
twelve sections of liver metastases a total of 100 samples of single
CD3 positive T cells were measured manually for their area (using
the Hamamatsu NDP viewer software).
All slides were scanned using the NDP Nanozoomer HT from
Hamamatsu Photonics. The NDP Nanozoomer produces virtual
images of full tissue scans which have been analyzed visually as
well as by automatic image processing algorithms. The full tissue
sections allow large scale histological evaluations with high
precision across the complete section. Thus, ambiguities due to
varying cell densities across the tissue can be avoided. We used a
resolution of 0.46 mm/pixel (406).
Figure 1. Conglomerates and single cells. Liver metastasis of colorectal cancer with strong T cell infiltrate (CD3 staining: dark red with
hematoxylin counterstaining, A: overview, digital magnification 106, B: conglomerate (magnification 406), C: single cells, (magnification 406).
doi:10.1371/journal.pone.0007847.g001
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NDP viewer. At the invasive margin of colorectal cancer
metastases or primary tumors, regions with visually high immune
cell densities and conglomerates (each field with 1 mm
2 size) were
selected randomly. Manual evaluation of stained immune cells was
performed (in duplicates) by two independent observers. Varia-
tions in the identified cell quantities between observers were noted
(see table 1). The results for each observer were expressed as the
number of positive stained cells/mm
2. Despite the fact that many
different image processing systems could be used, we here
implemented the procedure for assessing immune cell densities
in cell conglomerates using the Visiomorph software (VisioMorph,
Visiopharm, Denmark).
Statistical Evaluation
Statistical analyses were performed with SPSS 16.0 software
(SPSS, Chicago, IL). For the two-sample comparison of the
distribution of continuous variables, exact Mann-Whitney U-tests
were used. When comparing different tissues, the exact Kruskal-
Wallis test was used. Results with two-tailed P values ,.05 were
judged to be statistically significant.
Results
Measurement of Cell Area Sizes in Sections with Isolated
CD3 Positive T Cells
From twenty sections across primary colorectal cancer, ten
sections of normal colon mucosa, ten sections of normal liver and
twelve sections of liver metastases a total of 100 samples of single
CD3 positive T cells were measured manually for their area (see
methods). To avoid specific tissue biases, a quarter of the
measurements was done in liver tissue, a quarter in metastatic
tissue, one quarter in colorectal primary tumors and one quarter in
normal mucosa. No significant differences in area sizes were seen
between the four tissues (Kruskal-Wallis test, p=0.581). The
resulting average area of an isolated T cell comprised 51 mm
2
Table 1. Cell counts of T cells (CD3+) in thirty different fields of 1 mm
2 size.
Field # 1234567891 0
Manual1 157 184 223 336 384 387 375 648 672 493
Manual2 92 171 207 238 272 422 409 617 476 457
Automated 80 172 208 252 288 366 406 486 504 524
Abs. Diff. Man. 65 13 16 98 112 35 34 31 196 36
% Diff. Man. 41% 7% 7% 29% 29% 9% 9% 5% 29% 7%
Field # 11 12 13 14 15 16 17 18 19 20
Manual1 546 600 692 751 700 729 854 872 924 1080
Manual2 502 571 642 697 738 895 605 978 748 855
Automated 530 574 654 710 764 789 798 847 852 860
Abs. Diff. Man. 44 29 50 54 38 166 249 106 176 225
% Diff. Man. 8% 5% 7% 7% 5% 23% 29% 12% 19% 21%
Field # 21 22 23 24 25 26 27 28 29 30
Manual1 814 906 1214 991 1051 1172 1383 1472 1255 1981
Manual2 858 1221 933 1381 1484 1078 1190 1106 1514 2089
Automated 888 963 985 1073 1117 1121 1213 1313 1334 2161
Abs. Diff. Man. 44 315 281 390 433 94 193 366 259 108
% Diff. Man. 5% 35% 23% 39% 41% 8% 14% 25% 21% 5%
Fields with maximum differences between manual cell counts are highlighted.
Abs. Diff. Man.=Absolute Difference between Manual1 and Manual2, % Diff. Man.=Percentage Difference between Manual1 and Manual2.
doi:10.1371/journal.pone.0007847.t001
Table 2. Cell area sizes of T cells (CD3+) measured in
histological sections of different tissues with 2 mm thickness.
Liver Liver metastases Primary CRC Mucosa
57,2 52,6 39,9 53,2
62 47,8 50,7 61
62,6 64,7 37,8 49,3
29 47,7 46,4 66,1
33,4 53,6 32,4 51,6
48,8 53 40,8 63,6
43,4 59 62,6 50
54,8 41,3 80,1 49,6
58,8 49,7 53,8 59,8
41,1 62,2 47,6 69
46,8 43,4 55,3 70,5
42,6 46,6 75,9 47,2
60,2 46,3 58,2 46,6
56,2 63,2 48,1 37,8
42,7 37,1 67,3 64
64,2 59 57,6 60,1
61,3 48 45,5 36,7
50,5 33,9 59,3 39,3
40,7 37,3 51,1 38
51,2 46,8 46,8 56,2
63,7 46,9 50,5 52,9
46,9 44,8 61,3 42,4
39,8 46,7 76 27,5
42,6 62,4 55,6 38,3
31,5 50,1 50 59,3
doi:10.1371/journal.pone.0007847.t002
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2; standard deviation 10.65 mm
2). The
details on all measured cell areas in different tissues can be found
in table 2.
Comparison of the Manual Cell Counts for Two Observers
on Cell Conglomerates
Figure 2 depicts the results for the individual observers and for
the automated cell counting algorithm. Table 1 shows the
according quantitative values measured for the two observers
and the described automated algorithm as well as the observed
differences. With increasing numbers of stained cells the
divergence between the two observers with respect to the resulting
cell densities was remarkable (partly exceeding 400 cells/mm
2
difference). We calculated the variability as ranging from 5 to 41%
depending on the area size of the conglomerate. As can be seen in
figure 1, the estimation of cell densities in conglomerates by visual
inspection is extremely difficult (see figure 1B) which explains the
partly large differences in the manual evaluations. Especially in
large conglomerates the estimation is not only time consuming but
also extremely biased by the individual observer’s ability to
estimate area sizes. The observers were allowed to repeat their
calculations but this did not diminish the variability. A
representative example is shown in figure 3, where the observer
repeated the cell count for a single conglomerate six times. As
therapy selection is increasingly done depending on exact
thresholds, this clearly emphasizes the above mentioned funda-
mental need for a reliable method capable of objectively
estimating cell densities in conglomerates. To estimate the
importance of also incorporating conglomerates (besides single
cell counts) into quantitative immunhistological cell counts
compared to only considering the single cells we analyzed 10
fields of 10 different patients for single cells and for conglomerates
(figure 4). The data show massive differences between the
complete analysis and single cell counts only, rendering the
inclusion of conglomerates in quantitative slide evaluations
mandatory.
Figure 2. Cell counts for 30 different fields with one ore more conglomerates, each evaluated by two observers (‘‘Manual1’’ and
‘‘Manual2’’) and the here presented algorithm (‘‘Automated’’). Note the up to 41% variation between the observers at high cell counts
(1000-1.500). For quantitative data comparison see table 1.
doi:10.1371/journal.pone.0007847.g002
Figure 3. Repeated quantification (six times) of a large
conglomerate by one observer. Triangles show single values for
each repetition and thin vertical lines indicate range, thick horizontal
line indicates average value.
doi:10.1371/journal.pone.0007847.g003
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The schematic approach is depicted in figure 5. The here described
conglomerate and cell quantification procedure is embedded in a
complex automated image processing pipeline including segmentation,
color deconvolution and analyses of cellular morphology. The detailed
implementation can vary between different computational image
processing systems (Image J, VIS, Definiens, Alphelys etc.) and the
respective implementation details are beyond the scope of this paper.
Moreover, such algorithms are dependent on the specific tissue the
respective target antigen is studied in. Specific explanations regarding
image processing are therefore omitted here, because any implemen-
tation should somehow lead to the detection of single cells and
aggregated cell clusters (‘‘conglomerates’’). Instead, here we present a
general procedure for dealing with conglomerates in quantitative tissue
analysis, independent of individual systems.
In dependence on the immunohistological detection system, every
CD3 positive T cell is specified by a characteristic color and shape
(‘‘roundness’’). These two parameters were used to identify CD3
positivecellsinthetissue(‘‘targetobjects’’)eitherinisolatedformorin
form of conglomerates. Based on the target objects’ area size it was
classified into ‘‘single T cells’’ or ‘‘T cell conglomerates’’. If the area
size exceeded triple the observed lower range of area (28 mm
2 *
3=84mm
2)thetargetobjectwasclassifiedas‘‘Tcellconglomerates’’,
smaller objects were regarded as ‘‘single T cells’’ if within the normal
range of T cell sizes. ‘‘Single T cell’’ objects were counted per field
(1 mm
2each).Fora‘‘Tcellconglomerate’’itsareawasdividedbythe
average area of a single T cell (51 mm
2)t oo b t a i na ne s t i m a t eo ft h e
underlying cell density yielding an estimated T cell number. These T
cell numbers were added to the number of ‘‘single T cell’’ objects to
obtain a final estimation of cell densities for the given field.
Comparison of the Results from the Automated
Algorithm with the Manually Observed Numbers
Using 106 digital magnification, all manually counted fields
(1 mm
2 each) were re-analyzed using an automated algorithm
based on the following approach. The manually obtained cell
densities varied greatly across the two observers and accounted for
a deviation of the estimated cell numbers of approximately 10%.
The results are in line with other reports on inter-observer
Figure 4. Impact of cell counts from conglomerates on total cell counts in 10 individual 1 mm
2 fields from sections of 10 different
patients. Omitting conglomerates in the quantification would substantially distort the total cell counts.
doi:10.1371/journal.pone.0007847.g004
Figure 5. Exemplary workflow for the described algorithm.
Stained immune cells are either counted individually (where possible)
or the number of cells is estimated by the conglomerate surface. Both
results are added.
doi:10.1371/journal.pone.0007847.g005
Quantifying Cell Conglomerates
PLoS ONE | www.plosone.org 5 November 2009 | Volume 4 | Issue 11 | e7847variability in histology stating even higher deviations between two
observers [13]. This marked high inter-observer deviation is
avoided with the automated system. Figure 2 shows the observed
cell numbers for two independent observes in context of the
performed corresponding automated analysis. Each field is 1 mm
2
and contains one or more conglomerates and scattered single CD3
positive T cells.
Discussion
In diagnostic pathology the accurate determination of cell counts
is of substantial importance as histological cut-offs are increasingly
used as a basis for determining a patient’s individual therapy
strategy. Therefore, quantitative and objective methods are of
primaryconcern in diagnostics and clinical decisions[16], especially
in light of the accelerating automation of diagnostic routines. More
and more image processing algorithms are used for an automatic
pre-evaluation of tissue slides as a support for the diagnosing
pathologist [17]. In immunological evaluations, cell counting is
generally limited by the underlying quality and structure of the
studiedtissuesections.Forexample,overlappingcellsareofconcern
when assessing tissue sections of greater thickness. The sections used
here had a thickness of 2 mm, thus minimizing the possible overlap
between immune cells. T cells have a diameter of 6 to 15 mm.
Therefore, the here described procedure is untroubled also by
densely packed cell conglomerates (see figure 6).
We here dealt with the problem of incorporating complex cell
conglomerates into histological cell count cut-off studies. The
presented data shows an enormous impact of conglomerates on
calculated cell densities for a given field (see figure 4). Simply
ignoring conglomerates as it is done in some recent studies [15] is
not acceptable because this leads to severe bias, which is especially
devastating in clinically relevant settings where accurate evaluation
with regard to cut-offs may be crucial to patient treatment or
survival. In our view accurate counting also in conglomerates is
indispensible for determining quantitative immunological patient
responses. Image processing approaches including complex
mathematical operations dissecting the conglomerates by finding
local minimal and maximal staining intensities in an image
(‘‘watershed algorithms’’) could be considered, but generally are
prone to severe errors due to unavoidable staining variability. Our
approach here uses the reliable statistical and biological basis of
immune cell size to calculate cell densities in conglomerates. It is
applicable with widely used available software image analysis
systems (ImageJ, VisioMorph, Definiens, etc.) and can imple-
mented straight forward. The rather straight-forward mathemat-
ical image processing operations avoid complex computational
operations and parameter settings. In this respect, our approach is
very attractive especially for high-throughput quantifications of
immunohistological evaluations. In summary we have shown that
(1) quantification of immune cell conglomerates is indispensable
when quantitatively evaluating immunohistological slides for
immune cell markers and (2) an intuitive, high-throughput capable
procedure for the objective and robust quantification of immune
cell conglomerates.
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